Renal Denervation - APAC Analysis and Market Forecasts Summary Renal Denervation is an innovative technology offering an alternative solution for patients who are unable to lower their blood pressure through pharmaceutical means. It is estimated that over 22% of adults have high blood pressure, making hypertension one of the most prevalent global diseases. While this technology has not hit the market as quickly as originally expected, due in part to unmet endpoints in a clinical trial in 2013, GlobalData expects the renal denervation market to expand significantly in the coming years. This report will identify the unmet needs with current devices, discuss recently completed and ongoing clinical trial trends and how their results are expected to impact market landscape, and analyze the renal denervation market's outlook by geography and technology. This report examines the renal denervation market in five major APAC markets: Australia, China, India, Japan, and South Korea. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the APAC market. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions in using and evaluating the adoption of different types of renal denervation devices. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions Answered - What is the current and future renal denervation market outlook in APAC? What trends are affecting the APAC market? - What is the competitive landscape and market share of major players in the renal denervation space in North America? - What are the key, high growth markets that renal denervation manufacturers should expand into? Which market segments are growing the fastest? - What are the unmet needs with the renal denervation devices currently on the market? How will emerging technologies fulfill these unmet needs? - What is physician perception and market outlook of renal denervation devices? - What are the challenges and barriers that have hindered widespread adoption of renal denervation devices? Reasons To Buy - "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Market Access 3.1 The Symplicity HTN-3 Trial 3.2 Reimbursement 3.2.1 Europe 3.2.2 Russia 3.2.3 Australia 3.3 M&A/Key Partnerships 3.3.1 The Cardinal Health Acquisition of Cordis 3.3.2 The Boston Scientific Acquisition of Vessix Vascular 3.3.3 The Medtronic Acquisition of Ardian 4 Unmet Needs 4.1 Overview 4.2 Nerve Regeneration 4.3 Ambulatory Blood Pressure Readings 4.4 Expanded Indications for the Use of Renal Denervation 4.5 Intervention to Monitor Treatment Progress 4.6 Long-Term Effects 5 Competitive Assessment 5.1 Company Share Analysis 5.2 Major Players 5.2.1 Ablative Solutions 5.2.2 Boston Scientific 5.2.3 CardioSonic 5.2.4 Cordis Corporation 5.2.5 Kona Medical 5.2.6 Medtronic 5.2.7 ReCor Medical 5.2.8 Renal Dynamics 5.2.9 St. Jude Medical 5.2.10 Terumo 5.3 Emerging Players 6 Market Outlooks 6.1 Procedure Trends 6.2 Market Drivers and Barriers 6.2.1 Market Driver 1: Large Disease Prevalence 6.2.2 Market Driver 2: Expanding Indications 6.2.3 Market Barrier 1: Dependency on Clinical Trials 6.2.4 Market Barrier 2: Reimbursement 6.2.5 Market Barrier 3: Development of Competing Technology 6.3 Market Outlooks by Geography 6.3.1 Asia-Pacific 7 Appendix 7.1 Bibliography 7.2 Abbreviations 7.3 Methodology 7.3.1 Overview 7.3.2 Coverage 7.4 Forecasting Methodology 7.4.1 Overview 7.4.2 Patient Population 7.4.3 Procedure Volume by Type of Disease 7.4.4 Procedure Volume by Type of Device 7.4.5 Average Selling Price 7.5 Primary Research Efforts 7.6 About the Authors 7.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 7.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 7.6.3 Tyler Fletcher, BSc, Global Head of Medical Devices 7.7 About GlobalData 7.8 Contact Us 7.9 Disclaimer
List of Tables
Table 1: Mergers and Acquisitions/Key Partnership Table 2: Clinical Trials Currently Underway Assessing Other Indications for Renal Denervation Table 3: Key Clinical Trials Assessing Other Indications for Renal Denervation Table 4: Company Profile - Ablative Solutions Inc. Table 5: Ablative Solutions - SWOT Analysis, 2016 Table 6: Company Profile - Boston Scientific Table 7: Boston Scientific - SWOT Analysis, 2016 Table 8: Product Profile - Vessix Renal Denervation System Table 9: Company Profile - CardioSonic Inc. Table 10: CardioSonic. - SWOT Analysis, 2016 Table 11: Product Profile - TIVUS Renal Denervation System Table 12: Company Profile - Cordis Corporation Table 13: Cordis - SWOT Analysis, 2016 Table 14: Product Profile - RENLANE Renal Denervation System Table 15: Company Profile - Kona Medical Inc. Table 16: Kona Medical Inc. - SWOT Analysis, 2016 Table 17: Company Profile - Medtronic Table 18: Medtronic - SWOT Analysis, 2016 Table 19: Product Profile - Symplicity Flex Renal Denervation Catheter Table 20: Product Profile - Symplicity Spyral Renal Denervation Catheter Table 21: Company Profile - ReCor Medical Inc. Table 22: ReCor Medical, Inc. - SWOT Analysis, 2015 Table 23: Product Profile - Paradise Renal Denervation System Table 24: Company Profile - Renal Dynamics Table 25: Renal Dynamics - SWOT Analysis, 2015 Table 26: Product Profile - ReDy Renal Denervation System Table 27: Company Profile - St. Jude Medical Table 28: St. Jude Medical - SWOT Analysis, 2016 Table 29: Product Profile - EnligHTN Renal Denervation System Table 30: Company Profile - Terumo Table 31: Terumo - SWOT Analysis, 2016 Table 32: Product Profile - Iberis Rrenal Denervation System Table 33: Summary of Emerging Players and Associated Renal Denervation Technologies Table 34: Australia Renal Denervation Sales ($m) Forecast, 2012-2022 Table 35: China Renal Denervation Sales ($m) Forecast, 2012-2022 Table 36: India Renal Denervation Sales ($m) Forecast, 2012-2022 Table 37: Japan Renal Denervation Sales ($m) Forecast, 2012-2022 Table 38: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022
List of Figures
Figure 1: Steps Required Prior to Treatment with Renal Denervation Figure 2: Global Company Share Analysis - Renal Denervation Figure 3: Vessix V2 Renal Denervation Catheter Figure 4: RENLANE Renal Denervation Catheter Figure 5: Surround Sound Renal Denervation System Figure 6: Symplicity Spyral Renal Denervation Catheter Figure 7: Paradise Ultrasound Renal Denervation Catheter Figure 8: EnligHTN Renal Denervation System Figure 9: APAC Renal Denervation Market Value, 2012-2022 Figure 10: Australia Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 11: China Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 12: India Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 13: Japan Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 14: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022 Figure 15: Survey Breakdown by Profession
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the demRead More...
U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposableRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.